Wealthcare Advisory Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.56M | Sell |
15,360
-1,975
| -11% | -$676K | 0.11% | 163 |
|
|
2026
Q1 | $6.1M | Sell |
17,335
-4,846
| -22% | -$1.73M | 0.12% | 155 |
|
|
2025
Q4 | $7.26M | Buy |
22,181
+9,696
| +78% | +$3.08M | 0.14% | 133 |
|
|
2025
Q3 | $3.52M | Buy |
12,485
+1
| +0% | +$290 | 0.07% | 216 |
|
|
2025
Q2 | $3.49M | Sell |
12,484
-338
| -3% | -$95.8K | 0.08% | 206 |
|
|
2025
Q1 | $3.99M | Sell |
12,822
-491
| -4% | -$145K | 0.11% | 166 |
|
|
2024
Q4 | $3.47M | Buy |
13,313
+416
| +3% | +$123K | 0.1% | 175 |
|
|
2024
Q3 | $4.16M | Buy |
12,897
+211
| +2% | +$69K | 0.12% | 153 |
|
|
2024
Q2 | $3.96M | Sell |
12,686
-58
| -0.5% | -$17K | 0.12% | 138 |
|
|
2024
Q1 | $3.62M | Buy |
12,744
+1,198
| +10% | +$351K | 0.12% | 145 |
|
|
2023
Q4 | $3.33M | Buy |
11,546
+252
| +2% | +$68.7K | 0.13% | 130 |
|
|
2023
Q3 | $3.04M | Buy |
11,294
+523
| +5% | +$131K | 0.14% | 120 |
|
|
2023
Q2 | $2.39M | Buy |
10,771
+168
| +2% | +$39K | 0.11% | 158 |
|
|
2023
Q1 | $2.56M | Buy |
10,603
+1,751
| +20% | +$430K | 0.11% | 152 |
|
|
2022
Q4 | $2.33M | Buy |
8,852
+762
| +9% | +$204K | 0.11% | 146 |
|
|
2022
Q3 | $1.82M | Buy |
8,090
+84
| +1% | +$20.4K | 0.1% | 148 |
|
|
2022
Q2 | $1.95M | Sell |
8,006
-6
| -0.1% | -$1.47K | 0.12% | 120 |
|
|
2022
Q1 | $1.94M | Buy |
8,012
+63
| +0.8% | +$14.5K | 0.12% | 103 |
|
|
2021
Q4 | $1.79M | Sell |
7,949
-2,060
| -21% | -$435K | 0.11% | 114 |
|
|
2021
Q3 | $2.13M | Buy |
10,009
+297
| +3% | +$68.4K | 0.14% | 99 |
|
|
2021
Q2 | $2.37M | Sell |
9,712
-21
| -0.2% | -$5.17K | 0.16% | 91 |
|
|
2021
Q1 | $2.42M | Sell |
9,733
-16
| -0.2% | -$3.82K | 0.18% | 76 |
|
|
2020
Q4 | $2.24M | Buy |
9,749
+2,681
| +38% | +$618K | 0.2% | 70 |
|
|
2020
Q3 | $1.8M | Buy |
7,068
+37
| +0.5% | +$9.17K | 0.2% | 68 |
|
|
2020
Q2 | $1.66M | Sell |
7,031
-176
| -2% | -$40.2K | 0.21% | 63 |
|
|
2020
Q1 | $1.46M | Sell |
7,207
-20
| -0.3% | -$4.37K | 0.21% | 61 |
|
|
2019
Q4 | $1.74M | Buy |
7,227
+4,898
| +210% | +$1.08M | 0.22% | 61 |
|
|
2019
Q3 | $451K | Buy |
2,329
+290
| +14% | +$55.7K | 0.07% | 164 |
|
|
2019
Q2 | $376K | Buy |
2,039
+20
| +1% | +$3.58K | 0.06% | 171 |
|
|
2019
Q1 | $384K | Buy |
2,019
+41
| +2% | +$7.83K | 0.07% | 158 |
|
|
2018
Q4 | $385K | Sell |
1,978
-14
| -0.7% | -$2.73K | 0.07% | 134 |
|
|
2018
Q3 | $413K | Sell |
1,992
-16
| -0.8% | -$3.15K | 0.08% | 141 |
|
|
2018
Q2 | $371K | Buy |
2,008
+842
| +72% | +$149K | 0.07% | 147 |
|
|
2018
Q1 | $199K | Sell |
1,166
-43
| -4% | -$7.89K | 0.05% | 195 |
|
|
2017
Q4 | $210K | Buy |
1,209
+915
| +311% | +$162K | 0.05% | 170 |
|
|
2017
Q3 | $55K | Buy |
+294
| New | +$52.1K | 0.02% | 289 |
|
Other funds holding AMGN
FFM
SP
Wealthcare Advisory Partners's AMGN Position: Q2 2026 in Review
Wealthcare Advisory Partners reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $676K and leaving 15,360 shares worth $5.56M. The position accounts for 0.11% of the portfolio, ranked #163.
Wealthcare Advisory Partners first reported a position in AMGN in Q3 2017 and has held it in 36 quarters since. The position peaked at $7.26M in Q4 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Wealthcare Advisory Partners held 15,360 shares of Amgen worth $5.56M as of Q2 2026.
- Wealthcare Advisory Partners sold 1,975 Amgen shares in Q2 2026, an estimated $676K.
- Amgen made up 0.11% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #163 holding.
- Wealthcare Advisory Partners first reported a position in Amgen in Q3 2017 and has held it in 36 quarters since.
- Wealthcare Advisory Partners's Amgen position peaked at $7.26M in Q4 2025.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.